Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07785115
Active, not recruiting Not applicable

Full-Mouth vs. Quadrant-Wise Scaling and Root Planing: Clinical Effectiveness, Environmental Sustainability, and Patient-Reported Outcomes

NCT07785115 · tracked via the Priya Life Science Turkey tracker
Sponsor
Selcuk University
Phase
Not applicable
Started
2025-09-15
Last updated
2026-08-25

Condition(s) studied

Stage III Periodontitis

Investigational drug(s) / intervention(s)

Full-Mouth Scaling and Root PlaningQuadrant-Wise Scaling and Root Planing

Full-Mouth Scaling and Root Planing: Full-mouth scaling and root planing was completed in a single treatment session using ultrasonic scalers and Gracey curettes. Standardized oral hygiene instructions were provided before treatment. Participants were re-evaluated at 1-, 3-, and 6-month follow-up visits, and additional non-surgical periodontal treatment was provided for sites requiring further therapy when clinically indicated.Clinical outcomes, patient-reported outcomes, and the environmental impact of the treatment protocol were assessed throughout the study.

Quadrant-Wise Scaling and Root Planing: Quadrant-wise scaling and root planing was performed over four treatment sessions scheduled at one-week intervals using ultrasonic scalers and Gracey curettes. Standardized oral hygiene instructions were provided before treatment. Participants were re-evaluated at 1-, 3-, and 6-month follow-up visits, and additional non-surgical periodontal treatment was provided for sites requiring further therapy when clinically indicated. Clinical outcomes, patient-reported outcomes, and the environmental impact of the treatment protocol were assessed throughout the study.

Study summary

This randomized clinical trial compares full-mouth and quadrant-wise scaling and root planing in patients with Stage III periodontitis. In addition to evaluating clinical effectiveness and patient-reported outcomes, the study investigates the environmental sustainability of both treatment protocols using life cycle assessment. The findings are expected to contribute to more sustainable and patient-centered periodontal treatment planning.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: Age ≥18 years. Diagnosis of Stage III periodontitis according to the 2017 World Workshop -Classification of Periodontal and Peri-Implant Diseases and Conditions. Presence of at least four teeth in each quadrant, including at least one molar, excluding third molars. Absence of any systemic disease. No regular use of systemic medications. No history of periodontal treatment within the previous 6 months. No use of antibiotics, anti-inflammatory agents, or any other medications that could affect periodontal tissues within the previous 6 months. Non-smokers or individuals who had ceased smoking for at least 1 year prior to enrollment. Not pregnant or breastfeeding. Exclusion Criteria: Age \<18 years. Presence of any systemic disease. Regular use of systemic medications. History of periodontal treatment within the previous 6 months. Failure to complete the treatment protocol or attend scheduled follow-up visits. Current smoking. Use of antibiotics, anti-inflammatory agents, or any other medications that could affect the periodontal tissues within the previous 6 months. Requirement for antibiotic prophylaxis prior to dental treatment.

Primary outcome measure(s)

  • Probing Pocket Depth (PPD) — Baseline, 1 month, 3 months, and 6 months
    Mean probing pocket depth (PPD) was measured at six sites per tooth using a manual periodontal probe and recorded in millimeters (mm). Lower PPD values indicate improved periodontal status.

Trial sites (1)

FacilityCityRegionStatus
Selcuk University Faculty of Dentistry Konya Turkey (Türkiye)

More Selcuk University trials in Turkey

Validation of a Virtual Reality Timed Up and Go Test in Adults With Chronic Non-Specific Low Back Pain Starting soon
Respiratory Muscle Strength and Endurance Cut-Offs in Multiple Sclerosis Starting soon
Effects of Laughter Therapy on Postpartum Mothers' Stress, Sleep, and Breastfeeding Enrolling by invitation
Validity and Reliability of Mixed Reality-Based Performance Tests in Overweight and Obese Adults Recruiting
Virtual Reality-Based Functional Mobility Tests in Older Adults Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07785115 on ClinicalTrials.gov ↗ ← All trials in Turkey